Related Experiment Video
Updated: Aug 9, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Adaptive clinical trials and master protocols
Andrew McGarry1, Karl Kieburtz2
1Department of Neurology, Cooper University Healthcare at Rowan University, Camden, NJ, United States.
Abstract:
Methodologies for randomized, double-blind, placebo-controlled clinical trials continue to develop in concert with evolving scientific and translational knowledge. Adaptive trial designs, in which data generated during the study are used to modify subsequent study activity (i.e., sample sizes, entry criteria, or outcomes), can optimize flexibility and expedite the safety and efficacy assessments for interventions of interest. This chapter will summarize general designs, advantages, and pitfalls associated with adaptive clinical trials and compare their features with those of conventional trial designs. It will also review novel ways for which seamless designs and master protocols may improve trial efficiency while offering interpretable data.
Insights
Adaptive clinical trial designs offer greater flexibility and faster safety and efficacy assessments compared to conventional methods. These innovative approaches optimize trial efficiency and data interpretability for medical interventions.
Area of Science:
- Clinical Trials Methodology
- Translational Science
- Drug Development
Background:
- Randomized, double-blind, placebo-controlled clinical trials are fundamental in medical research.
- Evolving scientific knowledge necessitates advancements in clinical trial methodologies.
- Adaptive trial designs represent a significant evolution in clinical trial methodology.
Purpose of the Study:
- To summarize general designs, advantages, and pitfalls of adaptive clinical trials.
- To compare adaptive trial designs with conventional clinical trial designs.
- To review novel seamless designs and master protocols for improving trial efficiency.
Main Methods:
- Review of adaptive clinical trial designs.
- Comparison of adaptive and conventional trial designs.
- Exploration of seamless designs and master protocols.
Main Results:
- Adaptive designs allow for modifications (e.g., sample size, criteria) based on interim data.
- These designs can optimize flexibility and expedite safety and efficacy assessments.
- Seamless designs and master protocols offer potential improvements in trial efficiency and data interpretability.
Conclusions:
- Adaptive clinical trials enhance the efficiency and flexibility of evaluating medical interventions.
- Novel approaches like seamless designs and master protocols further optimize clinical trial processes.
- These advanced methodologies are crucial for accelerating the assessment of new treatments.
More Related Videos
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.